Pancreatitis,Acute NecrotizingREALAXIOSNCT04782414
Hot AXIOS® Prosthesis in Real Life Conditions -
An observational study of Pancreatitis,Acute Necrotizing, run by Centre Hospitalier Universitaire de Nice at 17 sites in France.
Trial summary
Regulatory Context The CNEDiMTS makes the renewal of registration conditional on the transmission of the results of a well-conducted prospective study, carried out with Hot AXIOS, the objective of which is to evaluate the interest of this device in real conditions of use with regard to effectiveness and complications… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Pancreatitis,Acute Necrotizing
- What is being tested?
- Hot AXIOS® prosthesis
- Type of treatment
- Surgery or procedure
- How many people
- 176 participants
- Where
- 17 sitesFrance
- Study dates
- 18 Apr 2021to 9 Nov 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: patients having benefited from the treatment of pancreatic collections
Who may be able to join
- Should benefit from the installation of a Hot Axios system as part of PBDA support, regardless of the indication.
- Age ≥ 18 years old,
- Having signed his or her no objection or the trusted person if the patient is unable to do so prior to the procedure
- Affiliated to a social security scheme
Who cannot join
- Patients who have indicated that they do not wish to participate in the study.
Trial locations and contacts
17 sites in 1 country.
17 sites in 1 country
France17 sites
Avignon Hospital
Avignon, 84000
brest Hospital
Brest, 29603
Clermont-ferrand hospital
Clermont-Ferrand, 63003
Polyclinique Saint Côme
Compiègne, 60204
Lille Hospital
Lille, 59037
Limoges hospital
Limoges, 87042
Clinique Jean Mermoz
Lyon, 69008
APHM
Marseille, 13000
European Hospital
Marseille, 13000
St Joseph Hospital
Marseille, 13000
Nancy Hospital
Nancy
Nice Hospital
Nice, 06000
APHP saint antoine
Paris, 75012
Hôpital privé des peupliers
Paris, 75013
Poitiers Hospital
Poitiers, 86021
Saint Etienne Hospital
Saint-Etienne, 42055
Centre Hospitalier Jacques Lacarin
Vichy, 03207
About this study
Official title: Observational Study of Patients Treated With Hot AXIOS® Prosthesis in Real Life Conditions -
Regulatory Context The CNEDiMTS makes the renewal of registration conditional on the transmission of the results of a well-conducted prospective study, carried out with Hot AXIOS, the objective of which is to evaluate the interest of this device in real conditions of use with regard to effectiveness and complications after a minimum follow-up of 3 months.
Operators are trained in the use of the equipment (practice on ex-vivo model and/or prior stent placement) and undertake to comply with the rules and formalities of use.
Read more
Primary efficacy objective :
To evaluate the efficacy of endoscopic trans digestive drainage after use of the Hot AXIOS prosthesis in the treatment of pancreatic collections (incompletely fluid or necrotic) at 3 months.
Secondary Objectives :
Assessment of the following elements :
- Morbidity (complication rates) and mortality per- and post-procedure
- Recurrence rate of pancreatic collection
- Evolution of the quality of life questionnaire (SQ5D5L)
- Technical success rate of prosthesis placement and removal success rate of the prosthesis
- Search for factors predictive of clinical success of endoscopic pancreatic drainage with the Hot Axios prosthesis.
Study design Non-interventional/observational (RIPH 3 type), multi-center, prospective study with consecutive inclusions evaluating the Hot AXIOS® prosthetic device.
Non-inclusion registry A minimum amount of information will be collected anonymously, including sex, age, indication of drainage and reason for non-inclusion (e.g. refusal of the patient, of the investigator for impossibility of following the patient in the centre or other reasons to be specified). Generic information will be affixed in each centre participating in the study indicating: "In application of the provisions of the Data Protection Act, general information on the possibility that personal data may be used for research purposes must be provided in any establishment or centre where prevention, diagnosis and care activities are carried out". This must be exhaustive and rigorously maintained.
Equipment used in endoscopy Hot AXIOS™ - self-expanding metal prosthesis with a lumen diameter of 6 to 20 mm and collar length of 8 and 10 mm or any future similar device marketed under the same name at the time of the study.
Technique Insertion of the material under echo-endoscopic control -- possible but not systematic dilatation -- guide wire with hydrophilic tip - Puncture and release under echo-endoscopic control according to the centre's usual practice.
Registration The data will be collected anonymously in an electronic computer database using eCRFs.
Statistical analysis The evaluation of the clinical success of endoscopic pancreatic necrosectomy with metallic prosthesis will first consist in describing its efficacy according to the criteria described above.
Analysis plan :
The statistical analysis will first include a description of the study population with the number of patients falling under the indication and treated with the Hot AXIOS system at the recruiting centers (source population), the number of eligible patients who consented to participate in the study, the number of patients included (study population), the number of subjects who made each visit and were analyzed, premature exits (deaths, lost to follow-up) will be reported and described in the form of a flow chart.
- Conditions
- Pancreatitis,Acute Necrotizing
- Being tested
- Hot AXIOS® prosthesis
- Medical subject headings
- Pancreatitis, Acute Necrotizing
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hot AXIOS® prosthesisProcedure or surgery
endoscopic trans digestive drainage using of the Hot AXIOS prosthesis in the treatment of pancreatic collections (incompletely fluid or necrotic)
What is being measured
The primary outcome is the main question the study is designed to answer.
patients with clinical success
reduction in the size of the pancreatic fluid collection ≤ 3 cm, evaluated by imaging
Measured: 3 months
Secondary outcomes (5)
Collect all complications,
Complications will be assessed according to Cotton's endoscopic classification26 (mild, moderate, severe, or fatal) [Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc.2010; 71: 446-54].
Measured: 3 months
recurrence of pancreatic collection
the presence of a collection of pancreatic origin on imaging of more than 3 cm at the 3-month check-up
Measured: 3 months
evolution of the quality of life questionnaire
Analyze the evolution of the quality of life questionnaire EQ5D5L, with as reference the one completed before the procedure
Measured: 3 months
Evaluate the technical success rate
success of the prosthesis in place at the end of the endoscopic procedure - determined by the correct trans parietal (gastric or duodenal) deployment (collar on either side of the digestive walls) and the technical success rate of the prosthesis removal (endoscopic extraction) and the date of the procedure.
Measured: 3 months
Look for factors predictive of clinical success
the predictive factors will be an aggregate of the folowing clinicals signs
- sex, age, body mass index, severity score (APACHE II), aetiology of pancreatitis, size of collection, proportion of solid debris in the collection, associated pancreatic ductal rupture, glandular extension and peritoneal extension of the necrosis , location of the gastrostomy , time between admission and completion of the procedure
- According to the clinical signs that motivated the intervention such as :
- Pain and/or, ii. Necrosis infection (positive culture of necrosis, presence of gas bubbles in the collection on imaging, persistent sepsis or deterioration of the patient's condition malgré́ an optimal resuscitation support without documented infection) and/or, iii. High occlusion (vomiting, food intolerance and gastric stasis on imaging) and/or, iv. Symptoms such as jaundice and/or, v. Organ failures such as kidney, heart, lung.
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Mar 2021
- Study start18 Apr 2021
- Primary completion9 Nov 2023
- Study completion9 Nov 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pancreatitis,Acute NecrotizingStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire de NiceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 176 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04782414
- Sponsor's protocol ID
- 19-PP-20
- Acronym
- REALAXIOS
- Status last verified
- May 2024
- First submitted
- 1 Mar 2021
- Last updated
- 17 May 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Observational Study of Patients Treated With Hot AXIOS® Prosthesis in Real Life Conditions -
- ClinicalTrials.gov ID
- NCT04782414
- Acronym / sponsor ID
- REALAXIOS / 19-PP-20
- Conditions
- Pancreatitis,Acute Necrotizing
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 176 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire de NiceUniversity, hospital or other
- Study start
- 18 Apr 2021 (actual)
- Primary completion
- 9 Nov 2023 (actual)
- Study completion
- 9 Nov 2023 (actual)
- First posted
- 4 Mar 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Regulatory Context The CNEDiMTS makes the renewal of registration conditional on the transmission of the results of a well-conducted prospective study, carried out with Hot AXIOS, the objective of which is to evaluate the interest of this device in real conditions of use with regard to effectiveness and complications after a minimum follow-up of 3 months.
Operators are trained in the use of the equipment (practice on ex-vivo model and/or prior stent placement) and undertake to comply with the rules and formalities of use.
Primary efficacy objective :
To evaluate the efficacy of endoscopic trans digestive drainage after use of the Hot AXIOS prosthesis in the treatment of pancreatic collections (incompletely fluid or necrotic) at 3 months.
Secondary Objectives :
Assessment of the following elements :
- Morbidity (complication rates) and mortality per- and post-procedure
- Recurrence rate of pancreatic collection
- Evolution of the quality of life questionnaire (SQ5D5L)
- Technical success rate of prosthesis placement and removal success rate of the prosthesis
- Search for factors predictive of clinical success of endoscopic pancreatic drainage with the Hot Axios prosthesis.
Study design Non-interventional/observational (RIPH 3 type), multi-center, prospective study with consecutive inclusions evaluating the Hot AXIOS® prosthetic device.
Non-inclusion registry A minimum amount of information will be collected anonymously, including sex, age, indication of drainage and reason for non-inclusion (e.g. refusal of the patient, of the investigator for impossibility of following the patient in the centre or other reasons to be specified). Generic information will be affixed in each centre participating in the study indicating: "In application of the provisions of the Data Protection Act, general information on the possibility that personal data may be used for research purposes must be provided in any establishment or centre where prevention, diagnosis and care activities are carried out". This must be exhaustive and rigorously maintained.
Equipment used in endoscopy Hot AXIOS™ - self-expanding metal prosthesis with a lumen diameter of 6 to 20 mm and collar length of 8 and 10 mm or any future similar device marketed under the same name at the time of the study.
Technique Insertion of the material under echo-endoscopic control -- possible but not systematic dilatation -- guide wire with hydrophilic tip - Puncture and release under echo-endoscopic control according to the centre's usual practice.
Registration The data will be collected anonymously in an electronic computer database using eCRFs.
Statistical analysis The evaluation of the clinical success of endoscopic pancreatic necrosectomy with metallic prosthesis will first consist in describing its efficacy according to the criteria described above.
Analysis plan :
The statistical analysis will first include a description of the study population with the number of patients falling under the indication and treated with the Hot AXIOS system at the recruiting centers (source population), the number of eligible patients who consented to participate in the study, the number of patients included (study population), the number of subjects who made each visit and were analyzed, premature exits (deaths, lost to follow-up) will be reported and described in the form of a flow chart.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- patients having benefited from the treatment of pancreatic collections
Key inclusion criteria (4 listed)
- Should benefit from the installation of a Hot Axios system as part of PBDA support, regardless of the indication.
- Age ≥ 18 years old,
- Having signed his or her no objection or the trusted person if the patient is unable to do so prior to the procedure
- Affiliated to a social security scheme
Key exclusion criteria (1 listed)
- Patients who have indicated that they do not wish to participate in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hot AXIOS® prosthesisendoscopic trans digestive drainage using of the Hot AXIOS prosthesis in the treatment of pancreatic collections (incompletely fluid or necrotic) | Procedure or surgery | – |
Primary outcome
patients with clinical success
Time frame: 3 months
reduction in the size of the pancreatic fluid collection ≤ 3 cm, evaluated by imaging
5 secondary outcomes
Collect all complications,
Time frame: 3 months
recurrence of pancreatic collection
Time frame: 3 months
evolution of the quality of life questionnaire
Time frame: 3 months
Evaluate the technical success rate
Time frame: 3 months
Look for factors predictive of clinical success
Time frame: 3 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 May 2024.
- Individual participant dataSharing planned: No
Related trials for Pancreatitis,Acute Necrotizing
RecruitingObservational study
DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis
Acute Pancreatitis
RecruitingObservational study
Organ Dysfunction Change in Acute Necrotizing Pancreatitis Patients With Sepsis After Open Necrosectomy
Necrotizing Pancreatitis
RecruitingObservational study
Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections
Acute Pancreatitis, Pancreatic Pseudocyst
Recruiting
Necrosectomy With Cryotechnology for Accelerated Removal
Pancreatic Necrosis, Acute Pancreatitis
RecruitingPhase 3
Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis
Acute Necrotizing Pancreatitis, Pancreatic Exocrine Insufficiency
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
17 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pancreatitis,Acute Necrotizing, run by Centre Hospitalier Universitaire de Nice at 17 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 17 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
patients with clinical success (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2024.